Navigation Links
Bio-Logic Aqua® Research Water Life Science® Shares Discoveries About Dry Eye & Tear FIlm
Date:4/7/2017

Sharon Kleyne, founder of Bio-Logic Aqua® Research Water Life Science® and host of the nationally syndicated radio program, The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health on VoiceAmerica, shared recent discoveries and findings from her research center suggesting that though people worldwide are conscious of saving water, they often ignore their own body water. “This is not good,” Kleyne insists. “A healthy understanding of water begins with a thorough understanding of water’s role in the functioning of one’s own body.”

Sharon Kleyne also agrees with a recent study that researchers must learn more about natural tears to better understand how to treat eyes that do not tear (eyes that suffer from dry eye). Such is the conclusion of a recent study conducted at the University of Western Sydney. Associate Professor M. Millar, director of the study, believes that researchers need to approach dry eyes “in a new, more constructive manner”. Kleyne, who has conducted groundbreaking research on dehydration of the body’s water vapor due to excessive evaporation for more than two decades, sees the need for more research because dry eye disease is on the rise around the world. “Everyone suffers dry eyes on occasion,” says Kleyne, “but billions of people are chronically afflicted with dry eye symptoms that can result in blindness.

“Natural tears,” Kleyne continues, “are essential to our wellness, to our health. Natural tears protect our eyes by lubricating them. They protect the cornea as well as the surrounding tissues.” Kleyne wants people to understand that tears are not just about crying. Yes, tears can appear to be plentiful when we feel sad or some other overpowering emotion, but natural tears moisten our eyes and keep them lubricated. Natural tears make it possible for our eyes to focus without obstructions. Simply put, natural tears help us to see clearly. “If we didn’t have natural tears,” says Kleyne, “we’d be looking at the world through a haze.”

According to professor Millar, whose study extended 14 years, we now know more about tears than ever before, but there is still more to discover. We do know now that the key to understanding dry eyes is to know how air interacts with the liquid tear in the eye and makes tears evaporate. Earlier, we believed that tears contained proteins that were found only in the teardrop. But new research discovered that proteins also exist at the surface and around the tear. These outer proteins, not those within the tear, determine how quickly tears will evaporate and cause dry eyes.

Sharon Kleyne believes that research like Millar’s study can lead to a cure for dry eye disease. Until now, researchers have focused mostly on studying and comprehending the internal workings of the tear. Now, researchers are focusing on the outer surface. In time, Kleyne believes, researchers will come up with new tools for slowing down the rate at which tears evaporate into the air. Millar and other researchers working at the University of Western Sydney, believe that the key to solving dry eyes will be to develop an almost natural teardrop that will evaporate slowly so that dry eyes become less and less of an issue.

Sharon Kleyne shares that dry eye disease symptoms include blurred vision, redness, burning, itching, stinging, a gritty sensation and watery eyes. These symptoms are triggered by a number of causes including pollution, allergies, post-menopausal changes, windy conditions, computer use, reading, television viewing and artificial environments (air conditioning, central heating). Kleyne described how she has also developed the only product on the world market that comes close to the ‘cure’ that Professor Millar envisions.

Nature’s Tears® EyeMist®, Kleyne points out, is applied with a personal hand-held humidifying device emitting a pure, pH balanced, 100% Trade Secret tissue culture grade water in a patented micron-size mist. It supplements the eye’s tear film, which is 99 percent water. Kleyne also refers to the fact that it is endorsed by more than 22,000 ophthalmologists and optometrists nationwide. The product was successfully test-marketed in more than 70,000 outlets. “With Natures Tears® EyeMist®,” Kleyne says, “tired and irritated eyes are supplemented with pure water, and that’s what eyes challenged by dry eye symptoms need. Eye drops may provide some temporary chemical relief,” Kleyne continues, “but they can become addictive and even make the dry eye condition worse.” Why? Because eye drops only trap water on the eye’s tear lens; they do not supplement the tear lens or the moisture (the tears) around it. Nature’s Tears® EyeMist® does supplement both.

“Dry eye disease is a billion dollar business,” Kleyne says, “and we must educate people about the short-and-long-term dangers of dry eye conditions. We must also move forward with new research and new technology so that we can stamp out this terrible disease once and for all.”

Read the full story at http://www.prweb.com/releases/2017/04/prweb14221300.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Bio-Logic Aqua® Research Water Life Science® Founder Sharon Kleyne Discusses Western Hiking Trails on Sharon Kleyne Hour® Radio Show
2. Bio-Logic Aqua® Research Water Life Science® Founder Sharon Kleyne Discusses Obama, UN Climate Change Conference in Paris Addressing Wrong Issues
3. Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission
4. Leading China Biogeneticist joins Bio-Logic Aqua® Research Dry Eye Product Rollout in China
5. Global Lyme Alliance Gala Raises Nearly $800K for Lyme and Tick-Borne Disease Research
6. The Society for Women’s Health Research Celebrates Three Outstanding Honorees
7. Pitt Researchers Identify New Brain Pathway
8. Atlanta’s NeuroTrials Research Studying Link Between Sleep and Parkinson’s Disease
9. Report Promotes Reforms to Teacher Education Programs but Ignores Past Research and Present Context
10. Renowned, Austin Facial Plastic Surgeon Contributes Ground-Breaking Research on Improving Hemostasis During Rhytidectomy Procedures
11. Advantexe Launches Strategy Execution Research Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... concussion rates are on the rise, say researchers presenting their work at the ... Ontario, Canada. , “The combination of evaluating the patterns of change in concussion ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia ... that progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and ... and relapse. With such a challenging diagnosis that requires immediate action, patients ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing homes, ... designed to accommodate patients with a wide range of ailments or special needs, but ... invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many uses, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... Doctors on Liens, ... addition of Horine Chiropractic , directed by Dr. Russell Horine, DC to their ... completely family run with Dr. Russell Horine serving as the clinic director and his ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... July 11, 2017  Sysmex America, Inc., a ... testing equipment as well as middleware information systems ... to make quality assurance easier and more risk ... well known for the innovation that it delivers ... elevates quality assurance processes to a new level ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
Breaking Medicine Technology: